Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial. - Gatzemeier,U.; Pluzanska,A.; Szczesna,A. (J Clin Oncol, 2007)